19 Nov BloodCenter of Wisconsin Names Roger D. Klein as medical director, molecular oncology
Milwaukee, Wis. – Roger D. Klein, M.D., J.D., has joined BloodCenter of Wisconsin http://www.bloodcenter.com/bins/site/templates/splash.asp as Medical Director of Molecular Oncology.
Dr. Klein will lead the development of BloodCenter of Wisconsin’s Diagnostic Laboratories’ newest initiative, which will focus on DNA- and RNA-based testing for evaluation of cancer patients. In partnership with BloodCenter of Wisconsin’s product development team, Dr. Klein will expand BloodCenter’s existing test menu to include new tests aimed at a variety of cancer diagnostics, including hematological cancers such as leukemia, lymphoma, and myeloproliferative disorders.
“Roger brings a wealth of experience to BloodCenter of Wisconsin. We are pleased that he has joined our Diagnostic Laboratories leadership team. His expertise will enable us to expand our services and help physicians diagnosis and treat patients with blood-related cancers,” said Ilke Panzer, vice president of Diagnostic Laboratories.
Dr. Klein comes to BloodCenter from H. Lee Moffitt Cancer Center where he served as Medical Director of Molecular Diagnostics and was an Assistant Professor in the Department of Oncologic Sciences, at the University of South Florida Medical School in Tampa, FL. Dr. Klein’s academic and clinical efforts focus on the translation of molecular genetic knowledge into clinical diagnostic tests.
In addition, Dr. Klein has an active research program involving the ethical, legal and social implications (ELSI) of the Human Genome Project, with particular emphasis on the areas of intellectual property and the regulation of in vitro diagnostics and clinical laboratories. Dr. Klein is a member of the CDC’s Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group and a consultant to the FDA’s Clinical and Molecular Genetics Advisory Panel. He also serves on the College of American Pathologists’ Molecular Oncology Resource Committee, and the Association for Molecular Pathology’s Professional Relations and CPT Coding Committees.
Dr. Klein earned his medical degree and completed an internship in Internal Medicine at Case Western Reserve University in Cleveland, OH. He completed residency training in Laboratory Medicine, together with fellowships in Medical Microbiology and Molecular Genetics, at Yale University School of Medicine in New Haven, CT, followed by a fellowship in Molecular Genetic Pathology at Mayo Clinic in Rochester, MN. In addition, Dr. Klein earned a law degree from Yale Law School. He is board-certified in Clinical Pathology and Molecular Genetic Pathology.
About BloodCenter of Wisconsin
BloodCenter of Wisconsin is a private, non-profit organization widely acclaimed as one of the top transfusion medicine organizations in the world and a leader in diagnostic testing of blood, blood research and blood collection. BloodCenter of Wisconsin is the only provider of blood to over 50 hospitals, including every community hospital in southeastern Wisconsin. It is also one of only four blood centers in the United States with a significant blood research program. Its Blood Research Institute (BRI) is devoted solely and uniquely to blood-related research.
Diagnostic Laboratories develop and perform highly specialized tests on patient samples from throughout the United States and the world. The highly specialized testing and expert medical consultation provided by the Diagnostic Laboratories benefit patients in need of bone marrow or organ transplants, patients with bleeding and clotting disorders and patients with immunologic, neoplastic, or genetic diseases. Customers rely on the services offered by BloodCenter’s Diagnostic Laboratories for expert assistance in solving complicated clinical issues.